Metabolomics Market by Technology (Mass Spectrometry, Capillary Electrophoresis, High Performance Liquid Chromatography, Gas Chromatography, and Nuclear Magnetic Resonance Spectroscopy), Indication (Cardiology and Oncology) for Drug Discovery, Biomarker and Nutrigenomics: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 - 2021
- ZIO1027736
- 110 Pages
- April 2016
- Materials and Chemicals
The report covers forecast and analysis for the metabolomics market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based revenue (USD Million). The study includes drivers and restraints for the market along with the impact they have on the demand over the forecast period. Additionally, the report includes study of opportunities available in the metabolomics market on a global level.
In order to give the users of this report a comprehensive view on the metabolomics market, we have included a detailed competitive scenario, and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter’s five forces model for the metabolomics market has also been included. The study encompasses a market attractiveness analysis, wherein technology segments are benchmarked based on their market size, growth rate and general attractiveness.
The study provides a decisive view on the metabolomics market is segmented on basis of technology, indication, application and region. High performance liquid chromatography, mass spectrometry, capillary electrophoresis, gas chromatography, and nuclear magnetic resonance spectroscopy are the technologies for metabolomics market. Applications include drug discovery, biomarker and nutrigenomics. Cardiology and oncology are the indication for metabolomics. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021.The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and Middle East and Africa with its further bifurcation into major countries including U.S. Germany, France, UK, China, Japan, India and Brazil.
The report covers detailed competitive outlook including company profiles of the key participants operating in the global market. Key players profiled in the report include Danaher Corporation, Bruker Corporation, Waters Corporation, Metabolon, Inc., Agilent Technologies, Thermo Fisher Scientific and Shimadzu Corporation among others.
This report segments for metabolomics market as follows:
Metabolomics Market: Technology Segment Analysis
- High performance liquid chromatography
- Mass spectrometry
- Capillary electrophoresis
- Gas chromatography
- Nuclear magnetic resonance spectroscopy
Metabolomics Market: Indication Segment Analysis
- Cardiology
- Oncology
Metabolomics Market: Application Segment Analysis
- Drug discovery
- Biomarker
- Nutrigenomics
Metabolomics Market: Regional Segment Analysis
- North America
- US
- Europe
- Germany
- France
- UK
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- Middle East and Africa
- Chapter 1. Introduction
- 1.1. Report description and scope
- 1.2. Research scope
- 1.3. Research methodology
- 1.3.1. Market research process
- 1.3.2. Market research methodology
- Chapter 2. Executive Summary
- 2.1. Global market revenue, 2015 - 2021(USD Million)
- 2.2. Global metabolomics market: Snapshot
- Chapter 3. Metabolomics Market – Global and Industry Analysis
- 3.1. Metabolomics : Market dynamics
- 3.2. Market drivers
- 3.2.1. Drivers of global metabolomics market: Impact analysis
- 3.2.2. Development of metabolomics data analysis software
- 3.2.3. Scope of toxicological studies and clinical trials
- 3.3. Market restraints
- 3.3.1. Restraints of global metabolomics market: Impact analysis
- 3.3.2. Validation of the process
- 3.3.3. Lack of adoption of metabolomics technology
- 3.4. Opportunities
- 3.4.1. Untapped demand from emerging economies
- 3.4.2. Surging research and development expenditure
- 3.5. Porter’s five forces analysis
- 3.6. Market Attractiveness Analysis
- 3.6.1. Market attractiveness analysis by technology segment
- 3.6.2. Market attractiveness analysis by indication segment
- 3.6.3. Market attractiveness analysis by application segment
- 3.6.4. Market attractiveness analysis by regional segment
- Chapter 4. Global Metabolomics Market - Competitive Landscape
- 4.1. Company market share, 2015
- 4.2. Price trend analysis
- Chapter 5. Global Metabolomics Market – Technology Segment Analysis
- 5.1. Global metabolomics market: technology overview
- 5.1.1. Global metabolomics market revenue share, by technology, 2015 - 2021
- 5.2. High performance liquid chromatography
- 5.2.1. Global high performance liquid chromatography market, by technology, 2015 – 2021 (USD Million)
- 5.3. Mass spectrometry
- 5.3.1. Global mass spectrometry market, by technology, 2015 – 2021 (USD Million)
- 5.4. Capillary electrophoresis
- 5.4.1. Global capillary electrophoresis market, by technology, 2015 – 2021 (USD Million)
- 5.5. Gas chromatography
- 5.5.1. Global gas chromatography market, by technology, 2015 – 2021 (USD Million)
- 5.6. Nuclear magnetic resonance spectroscopy
- 5.6.1. Global nuclear magnetic resonance spectroscopy market, by technology, 2015 – 2021 (USD Million)
- 5.1. Global metabolomics market: technology overview
- Chapter 6. Global Metabolomics Market – Indication Segment Analysis
- 6.1. Global metabolomics market: indication overview
- 6.1.1. Global metabolomics market revenue share, by indication, 2015 - 2021
- 6.2. Cardiology
- 6.2.1. Global cardiology market, by indication, 2015 – 2021 (USD Million)
- 6.3. Oncology
- 6.3.1. Global oncology market, by indication, 2015 – 2021 (USD Million)
- 6.1. Global metabolomics market: indication overview
- Chapter 7. Global Metabolomics Market – Applications Segment Analysis
- 7.1. Global metabolomics market: indication overview
- 7.1.1. Global metabolomics market revenue share, by indication, 2015 - 2021
- 7.2. Drug discovery
- 7.2.1. Global drug discovery market, by indication, 2015 – 2021 (USD Million)
- 7.3. Biomarker
- 7.3.1. Global biomarker market, by indication, 2015 – 2021 (USD Million)
- 7.4. Nutrigenomics
- 7.4.1. Global nutrigenomics market, by indication, 2015 – 2021 (USD Million)
- 7.1. Global metabolomics market: indication overview
- Chapter 8. Global Metabolomics market – Regional Segment Analysis
- 8.1. Global metabolomics market: Regional overview
- 8.1.1. Global metabolomics market revenue share by region, 2015 - 2021
- 8.2. North America
- 8.2.1. North America metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
- 8.2.2. North America metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
- 8.2.3. North America metabolomics market revenue, by application, 2015 – 2021 (USD Million)
- 8.2.3.1. U.S.
- 8.2.3.1.1. U.S. metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
- 8.2.3.1.2. U.S. metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
- 8.2.3.1.3. U.S. metabolomics market revenue, by application, 2015 – 2021 (USD Million)
- 8.2.3.1. U.S.
- 8.3. Europe
- 8.3.1. Europe metabolomics market revenue, by a technology, 2015 – 2021 (USD Million)
- 8.3.2. Europe metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
- 8.3.3. Europe metabolomics market revenue, by application, 2015 – 2021 (USD Million)
- 8.3.3.1. Germany
- 8.3.3.1.1. Germany metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
- 8.3.3.1.2. Germany metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
- 8.3.3.1.3. Germany metabolomics market revenue, by application, 2015 – 2021 (USD Million)
- 8.3.3.2. France
- 8.3.3.2.1. France metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
- 8.3.3.2.2. France metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
- 8.3.3.2.3. France metabolomics market revenue, by application, 2015 – 2021 (USD Million)
- 8.3.3.3. UK
- 8.3.3.3.1. UK metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
- 8.3.3.3.2. UK metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
- 8.3.3.3.3. UK metabolomics market revenue, by application, 2015 – 2021 (USD Million)
- 8.3.3.1. Germany
- 8.4. Asia Pacific
- 8.4.1. Asia Pacific metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
- 8.4.2. Asia Pacific metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
- 8.4.3. Asia Pacific metabolomics market revenue, by application, 2015 – 2021 (USD Million)
- 8.4.3.1. China
- 8.4.3.1.1. China metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
- 8.4.3.1.2. China metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
- 8.4.3.1.3. China metabolomics market revenue, by application, 2015 – 2021 (USD Million)
- 8.4.3.2. Japan
- 8.4.3.2.1. Japan metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
- 8.4.3.2.2. Japan metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
- 8.4.3.2.3. Japan metabolomics market revenue, by application, 2015 – 2021 (USD Million)
- 8.4.3.3. India
- 8.4.3.3.1. India metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
- 8.4.3.3.2. India metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
- 8.4.3.3.3. India metabolomics market revenue, by application, 2015 – 2021 (USD Million)
- 8.4.3.1. China
- 8.5. Latin America
- 8.5.1. Latin America metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
- 8.5.2. Latin America metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
- 8.5.3. Latin America metabolomics market revenue, by application, 2015 – 2021 (USD Million)
- 8.5.3.1. Brazil
- 8.5.3.1.1. Brazil metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
- 8.5.3.1.2. Brazil metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
- 8.5.3.1.3. Brazil metabolomics market revenue, by application, 2015 – 2021 (USD Million)
- 8.5.3.1. Brazil
- 8.6. Middle East and Africa
- 8.6.1. Middle East and Africa metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
- 8.6.2. Middle East and Africa metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
- 8.6.3. Middle East and Africa metabolomics market revenue, by application, 2015 – 2021 (USD Million)
- 8.1. Global metabolomics market: Regional overview
- Chapter 9. Company Profile
- 9.1. Danaher Corporation
- 9.1.1. Overview
- 9.1.2. Financials
- 9.1.3. Product portfolio
- 9.1.4. Business strategy
- 9.1.5. Recent developments
- 9.2. Bruker Corporation
- 9.2.1. Overview
- 9.2.2. Financials
- 9.2.3. Product portfolio
- 9.2.4. Business strategy
- 9.2.5. Recent developments
- 9.3. Waters Corporation
- 9.3.1. Overview
- 9.3.2. Financials
- 9.3.3. Product portfolio
- 9.3.4. Business strategy
- 9.3.5. Recent developments
- 9.4. Metabolon, Inc.
- 9.4.1. Overview
- 9.4.2. Financials
- 9.4.3. Product portfolio
- 9.4.4. Business strategy
- 9.4.5. Recent developments
- 9.5. Agilent Technologies
- 9.5.1. Overview
- 9.5.2. Financials
- 9.5.3. Product portfolio
- 9.5.4. Business strategy
- 9.5.5. Recent developments
- 9.6. Thermo Fisher Scientific
- 9.6.1. Overview
- 9.6.2. Financials
- 9.6.3. Product portfolio
- 9.6.4. Business strategy
- 9.6.5. Recent developments
- 9.7. Shimadzu Corporation
- 9.7.1. Overview
- 9.7.2. Financials
- 9.7.3. Product portfolio
- 9.7.4. Business strategy
- 9.7.5. Recent developments
- 9.8. Others
- 9.8.1. Overview
- 9.8.2. Financials
- 9.8.3. Product portfolio
- 9.8.4. Business strategy
- 9.8.5. Recent developments
- 9.1. Danaher Corporation
Similar Reports
Photonic Crystals are attractive optical materials for controlling and manipulating the flow of light. The global market for components and modules using Photonic Crystals indicates a CAGR of 33.1% and is estimated to reach $20.4 billion in 2017.
Nanomaterials possess nanoscale dimensions ranging from 1 to 100 nanometers. They occur naturally or can be engineered with specific properties such as size, shape, surface, and chemistry. Volcanic ash and forest fibers are some of the examples of natural nano...
- Publish Date: September 10, 2016
- $5820
Global molded plastics market was valued at $529,845 million in 2016, and is expected to garner $690,158 million by 2023, registering a CAGR of 3.9% from 2017 to 2023. Molded plastics are synthetically produced non-metallic compounds, which can be molded ...
- Publish Date: July 4, 2017
- $5370
